These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8917017)

  • 1. The impact of maternal age on the cost effectiveness of Down's syndrome screening.
    Macintosh MC
    Br J Obstet Gynaecol; 1996 Nov; 103(11):1175-7. PubMed ID: 8917017
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of maternal age on the cost effectiveness of Down's syndrome screening.
    Torgerson DJ
    Br J Obstet Gynaecol; 1996 Jun; 103(6):581-3. PubMed ID: 8645654
    [No Abstract]   [Full Text] [Related]  

  • 3. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Down's syndrome.
    Keatinge RM; Williams ES
    BMJ; 1991 Oct; 303(6809):1063. PubMed ID: 1835415
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cost effectiveness analysis of prenatal screening of trisomy 21 by maternal serum markers (hCG)].
    Seror V; Moatti JP; Muller F; Le Gales C; Boue A
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(8):915-22. PubMed ID: 1491137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies.
    Gilbert RE; Augood C; Gupta R; Ades AE; Logan S; Sculpher M; van Der Meulen JH
    BMJ; 2001 Aug; 323(7310):423-5. PubMed ID: 11520837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal screening for Down's syndrome.
    Gutteridge W
    BMJ; 1992 Sep; 305(6856):768; author reply 771. PubMed ID: 1422337
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood].
    Seror V; Moatti JP; Muller F; Le Galès C; Boué A
    Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appraisal of a new scheme for prenatal screening for Down's syndrome.
    Sheldon TA; Simpson J
    BMJ; 1991 May; 302(6785):1133-6. PubMed ID: 1710520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal screening for Down's syndrome.
    Wald NJ; Kennard A; Hackshaw A; McGuire A
    J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of prenatal diagnosis intervention for Down's syndrome in China.
    Chen Y; Qian X; Li J; Zhang J; Chu A; Schweitzer SO
    Int J Technol Assess Health Care; 2007; 23(1):138-45. PubMed ID: 17234028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using decision analysis to compare policies for antenatal screening for Down's syndrome.
    Fletcher J; Hicks NR; Kay JD; Boyd PA
    BMJ; 1995 Aug; 311(7001):351-6. PubMed ID: 7640539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of maternal age on the cost effectiveness of Down's syndrome screening.
    Dunstan FD; Nix AB
    Br J Obstet Gynaecol; 1997 Feb; 104(2):269-70. PubMed ID: 9070155
    [No Abstract]   [Full Text] [Related]  

  • 15. The prospects for "preventing" Down's syndrome in an English region.
    Forster DP
    Rev Epidemiol Sante Publique; 1980 Dec; 28(4):423-30. PubMed ID: 6452660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal screening for Down's syndrome.
    Macri VJ; Clark R
    BMJ; 1992 Sep; 305(6856):768; author reply 771. PubMed ID: 1422338
    [No Abstract]   [Full Text] [Related]  

  • 17. Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screening.
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12420332
    [No Abstract]   [Full Text] [Related]  

  • 18. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal screening for Down's syndrome.
    Bhatti N; Mackie A
    BMJ; 1992 Sep; 305(6856):770; author reply 771. PubMed ID: 1422342
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.